Boehringer-Ingelheim's pramipexole shows efficacy in Parkinson's-related depression
This article was originally published in Scrip
Executive Summary
Boehringer Ingelheim's dopamine agonist, Mirapex (pramipexole), can alleviate depression in Parkinson's disease, according to a study presented recently at the American Academy of Neurology (AAN) meeting in Seattle.